Back to all peptides
Healing & Recovery

Larazotide

Larazotide acetate · AT-1001 · zonulin antagonist
researchpopularoral capsule

What it is

Larazotide is an 8-amino-acid peptide that targets tight junctions in the gut lining. It blocks the action of zonulin (the protein that opens up gut tight junctions), helping reverse "leaky gut." Originally developed by 9 Meters Biopharma for celiac disease and made it to Phase 3 trials. The most evidence-based "leaky gut" intervention.

How it works

Antagonizes zonulin signaling at the gut epithelium. Tightens the spaces between intestinal cells, reducing the passage of large molecules (like undigested food proteins or bacterial fragments) into the bloodstream. Result: less systemic inflammation and immune activation from gut sources.

Benefits

Timeline

Week 2–4
Possible reduction in GI symptoms.
Month 1–3
Cumulative gut barrier improvements.

Dosing & titration

Standard dose0.5–1 mg orally, 3x daily before meals
Cycle length8–12 weeks, then assess
Timing15–30 min before each meal
When to titrate upPhase 3 trial dose was 0.5 mg 3x daily. Higher doses didn't improve outcomes in trials.

Side effects & risks

Best paired with addressing root cause (gluten exposure, dysbiosis, etc.). Larazotide is not a magic bullet on its own.

Typical price

$80–$200/moCompounded oral capsules from a 503A pharmacy.

Studies

Educational reference only. Not medical advice.